Nymox Pharmaceutical
NYMX
#8005
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-52.38%
Change (1 year)
Categories
Nymox Pharmaceutical (NYMX) - Total debt
Total debt on the balance sheet as of June 2023 : $0.8 M
According to Nymox Pharmaceutical's latest financial reports the company's total debt is $0.8 M. A company’s total debt is the sum of all current and non-current debts.
Nymox Pharmaceutical - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.17 M | -55.75% |
| 2021-12-31 | $0.39 M | -8.22% |
| 2020-12-31 | $0.42 M | 189.8% |
| 2019-12-31 | $0.14 M | |
| 2016-12-31 | $0.93 M | 14.26% |
| 2015-12-31 | $0.81 M | 13.33% |
| 2014-12-31 | $0.71 M | |
| 2008-12-31 | $0.01 M | -37.5% |
| 2007-12-31 | $0.02 M | -95.21% |
| 2006-12-31 | $0.53 M | -1.77% |
| 2005-12-31 | $0.54 M | -9.18% |
| 2004-12-31 | $0.6 M | 20% |
| 2003-12-31 | $0.5 M | -8.24% |
| 2002-12-31 | $0.54 M | 37.33% |
| 2001-12-31 | $0.39 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 3,643,626.71% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 8,800,521.12% | 🇺🇸 USA |
 Abbott Laboratories ABT | $15.62 B | 1,941,266.46% | 🇺🇸 USA |
 Eli Lilly LLY | $25.22 B | 3,133,477.64% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $5.49 B | 682,881.37% | 🇺🇸 USA |